Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.

Ricci, Daniela et al.·International immunopharmacology·2023·
RPEP-073182023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
Published In:
International immunopharmacology, 117, 109996 (2023)
Database ID:
RPEP-07318

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07318·https://rethinkpeptides.com/research/RPEP-07318

APA

Ricci, Daniela; Etna, Marilena Paola; Severa, Martina; Fiore, Stefano; Rizzo, Fabiana; Iannetta, Marco; Andreoni, Massimo; Balducci, Stefano; Stefanelli, Paola; Palamara, Anna Teresa; Coccia, Eliana Marina. (2023). Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.. International immunopharmacology, 117, 109996. https://doi.org/10.1016/j.intimp.2023.109996

MLA

Ricci, Daniela, et al. "Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.." International immunopharmacology, 2023. https://doi.org/10.1016/j.intimp.2023.109996

RethinkPeptides

RethinkPeptides Research Database. "Novel evidence of Thymosin α1 immunomodulatory properties in..." RPEP-07318. Retrieved from https://rethinkpeptides.com/research/ricci-2023-novel-evidence-of-thymosin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.